Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · IEX Real-Time Price · USD
7.56
-0.50 (-6.20%)
At close: Jul 2, 2024, 4:00 PM
7.80
+0.24 (3.17%)
After-hours: Jul 2, 2024, 5:20 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $212.19 million as of July 2, 2024.
Market Cap
212.19M
Enterprise Value
124.61M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.56
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $212.19M, a decrease of -40.41%. That is a compound annual growth rate of -90.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 226.20M | -36.48% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ESSA Pharma | 233.35M |
| Delcath Systems | 232.57M |
| AirSculpt Technologies | 230.28M |
| Monte Rosa Therapeutics | 228.70M |
| Nektar Therapeutics | 228.18M |
| Zura Bio | 222.89M |
| Atai Life Sciences | 222.65M |
| Greenwich LifeSciences | 222.31M |